Interestingly, when evaluating the expression profile of each T-cell marker, we found that patients-specific metaclusters showed a lower proportion of CD62L+ (p<0.001) and of CD28+ (p<0.05) cells compared to HD-specific metaclusters (Figure 4C), indicating a more differentiated phenotype associated to the disease. This evidence concerns the gene SELL and Huntington disease.